Donal is an experienced corporate officer in the technology and diagnostics sectors, having business leadership experience from start-up through to large corporate enterprise. He is an innovator with a proven track record in developing products from concept to market. Donal holds a Degree and Ph.D. in Biotechnology from Dublin City University, where he was also a member of the academic staff in the School of Biotechnology from 1999 to 2009. During this time, he published in excess of 20 peer reviewed manuscripts and was integral in the foundation of the MSc in Bioinformatics programme. Donal has founded three companies, Pixalert, Slidepath, and most recently, Accelesys. Slidepath was sold to Genetix Group PLC in 2009. Donal was a member of the Genetix Executive Management Team that sold Genetix to Danaher Corp for $100M. After joining Danaher, he worked in various general management roles (Head of Digital Pathology for Leica Microsystems, VP for Clinical Microscopy and Cytogenetics and the VP for Image Analysis and Clinical Systems at Leica Biosystems) and also supported various ongoing M&A projects, being part of the team that successfully acquired and integrated Aperio Technologies in 2012.